News-Medical speaks to David Dambman from Biosero about the emerging importance of automation in scientific research and how a centralized scheduling software is an essential first step for any ...

Life sciences software startup Artificial Inc. today disclosed that it has reeled in a $21.5 million funding round led by Microsoft Corp.’s M12 venture capital arm. The investment comes as Microsoft ...